These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 2880735

  • 1. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.
    Johnson MP, Hoffman AJ, Nichols DE.
    Eur J Pharmacol; 1986 Dec 16; 132(2-3):269-76. PubMed ID: 2880735
    [Abstract] [Full Text] [Related]

  • 2. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD, Nichols DE, Yim GK.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126
    [Abstract] [Full Text] [Related]

  • 3. Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues.
    Nichols DE, Oberlender R, Burris K, Hoffman AJ, Johnson MP.
    Pharmacol Biochem Behav; 1989 Nov 15; 34(3):571-6. PubMed ID: 2623014
    [Abstract] [Full Text] [Related]

  • 4. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.
    McKenna DJ, Guan XM, Shulgin AT.
    Pharmacol Biochem Behav; 1991 Mar 15; 38(3):505-12. PubMed ID: 1829838
    [Abstract] [Full Text] [Related]

  • 5. Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices.
    Fitzgerald JL, Reid JJ.
    Eur J Pharmacol; 1990 Nov 27; 191(2):217-20. PubMed ID: 1982265
    [Abstract] [Full Text] [Related]

  • 6. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Mar 27; 244(3):977-82. PubMed ID: 2472482
    [Abstract] [Full Text] [Related]

  • 7. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 27; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 8. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP, Conarty PF, Nichols DE.
    Eur J Pharmacol; 1991 Jul 23; 200(1):9-16. PubMed ID: 1685125
    [Abstract] [Full Text] [Related]

  • 9. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP, Nichols DE.
    Pharmacol Biochem Behav; 1989 May 23; 33(1):105-8. PubMed ID: 2476831
    [Abstract] [Full Text] [Related]

  • 10. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ, Robinson SE, Rosecrans JA.
    Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440
    [Abstract] [Full Text] [Related]

  • 11. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
    Hekmatpanah CR, Peroutka SJ.
    Eur J Pharmacol; 1990 Feb 20; 177(1-2):95-8. PubMed ID: 1971219
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA, Takeda H, Cho AK, Howard SG.
    Eur J Pharmacol; 1989 Sep 13; 168(2):209-17. PubMed ID: 2575036
    [Abstract] [Full Text] [Related]

  • 13. Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs.
    Schmidt CJ.
    Eur J Pharmacol; 1987 Apr 07; 136(1):81-8. PubMed ID: 2885204
    [Abstract] [Full Text] [Related]

  • 14. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
    O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 07; 25(3):621-38. PubMed ID: 11371001
    [Abstract] [Full Text] [Related]

  • 15. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
    Li AA, Marek GJ, Vosmer G, Seiden LS.
    Pharmacol Biochem Behav; 1989 Jul 07; 33(3):641-8. PubMed ID: 2573905
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
    Schmidt CJ, Levin JA, Lovenberg W.
    Biochem Pharmacol; 1987 Mar 01; 36(5):747-55. PubMed ID: 2881549
    [Abstract] [Full Text] [Related]

  • 17. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Callaway CW, Johnson MP, Gold LH, Nichols DE, Geyer MA.
    Psychopharmacology (Berl); 1991 Mar 01; 104(3):293-301. PubMed ID: 1924637
    [Abstract] [Full Text] [Related]

  • 18. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.
    Yamamoto BK, Spanos LJ.
    Eur J Pharmacol; 1988 Mar 29; 148(2):195-203. PubMed ID: 2897922
    [Abstract] [Full Text] [Related]

  • 19. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.
    Gough B, Ali SF, Slikker W, Holson RR.
    Pharmacol Biochem Behav; 1991 Jul 29; 39(3):619-23. PubMed ID: 1723797
    [Abstract] [Full Text] [Related]

  • 20. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM, Stahl DC, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):41-8. PubMed ID: 2875893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.